Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT (MTA)
Reversible Pulpitis, Dental Pulp Diseases
About this trial
This is an interventional treatment trial for Reversible Pulpitis focused on measuring Pulp, pulpotomies, mineral trioxide aggregate
Eligibility Criteria
Inclusion Criteria:
• Children between the ages of 2 ½ and 8 years of age
- Patient must have two, contralateral primary molars that are matched for type of molar (first or second), size of carious lesion (same level of approximation of carious lesion to the pulp), and arch (maxillary or mandibular) that are treatment planned for a pulpotomy
- The teeth selected for the study must be vital and asymptomatic both clinically and radiographically or only display symptoms consistent with reversible pulptitis
- The teeth selected for the study must be anticipated to be retained in the mouth for at least two years
- Each patient must have an updated medical history form in the dental record, be examined by the operator, and be classified as ASA I or II (in good general health)
Exclusion Criteria:
- Teeth with a history of spontaneous pain
- Teeth with radiographic evidence of internal or external resorption, intraradicular or periapical bone loss, loss of lamina dura, or widening of the periodontal ligament space
Sites / Locations
- Texas A & M University Baylor College of Dentistry
Arms of the Study
Arm 1
Arm 2
Experimental
Other
NeoMTA
ProRoot MTA
The new formulation of MTA (does not contain bismuth oxide) will be used in one tooth receiving a pulpotomy to determine if the color of the tooth changes over time. The new formulation has received the Food and Drug Administrations 510(k) substantial equivalence clearance for Class II dental materials and is equivalent to its MTA predicate (ProRoot, Dentsply Tulsa Dental, Tulsa, OK, USA).19
Control group. This group will receive the old formulation of MTA in the pulpotomy and the tooth will receive a full coverage stainless steel crown restoration.